Scores of virtual events are afoot around the world to mark Rare Disease Day 2021 on Feb. 28. The…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
The Cure Sanfilippo Foundation will be among those presenting posters at the WORLDSymposium 2021 conference on lysosomal storage disorders…
While progress was made last year on newborn screening and other policy issues critical to rare disease patients, a “…
Caring for a loved one with a rare disease, especially during these uncertain times, demands significant time, attention, patience, and…
Palliative Care for Sanfilippo Syndrome
There may come a time when you will need to consider palliative care for your child with Sanfilippo syndrome, and…
Developing a Treatment Plan for Sanfilippo Syndrome
Sanfilippo syndrome is a neurodegenerative disorder that affects about one in 70,000 births. Because it’s rare, many physicians are unfamiliar…
The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to…
Clinical trials are an essential step in treatment development, yet the many people they could potentially help are either…
If your child has been diagnosed with Sanfilippo syndrome, you may be feeling mixed emotions, from shock to concern to…
To empower and equip members of the rare disease community to engage state leaders in matters of importance to patients…